MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more
Profile
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.2B
P/E Ratio
N/A
Total Cash
277.67M
Projected Growth
N/A
Total Debt
317.16M
Revenue
379.25M
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
5.61
Total Debt/Equity
N/A
Revenue/Share
7.90 USD as % of share price
Fundamentals
MIRM
Capitalization
2.2B
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
278M
Total Cash/Share
5.61
Total Debt
317M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.90%
Revenue
379M
ROE
N/A
Book Value
233M
P/B Ratio
9.60
Cash Flow
N/A
Earnings
-1.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.22
Current Revenue Per Employee
346537.28
Dividends Per Share - Security
N/A
EBITDA
-37.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
79.37
Revenue To Assets
-11.52
Shares Held By Institutions
3.54B
Shares Outstanding - Current
49.5M
Total Liabilities
457M
Total Volume MTD
N/A
Value
N/A
Gain YTD
7.352
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com